Clincosm LogoSign in Get a demo

acute myeloid leukemia

Showing NaN - NaN of 178
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in United States (Quizartinib, Milademetan)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +7 more
Mar 14, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • SY-1425 (tamibarotene)
  • +2 more
  • Hartford, Connecticut
  • +25 more
May 4, 2022

Acute Myeloid Leukemia Trial in Canada, Puerto Rico, United States (procedure, drug, behavioral)

Recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +13 more
  • Birmingham, Alabama
  • +187 more
Apr 28, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine and

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Decitabine and Cedazuridine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 19, 2022

Blastic Plasmacytoid Dendritic Cell Tumor, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Worldwide (IMGN632)

Recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • +3 more
  • Gilbert, Arizona
  • +14 more
Apr 20, 2022

Advanced Solid Tumor, Non Hodgkin Lymphoma, Acute Myeloid Leukemia Trial in United States (BTX-1188)

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Duarte, California
  • +3 more
Apr 18, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Decitabine and

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 1, 2022

Acute Myeloid Leukemia Trial in Worldwide (Alvocidib, Cytarabine, Mitoxantrone)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +37 more
Apr 4, 2022

Acute Myeloid Leukemia Trial in United States (Tamibarotene, Venetoclax, Azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +7 more
Mar 27, 2022

Acute Myeloid Leukemia Trial in Worldwide (Uproleselan, Placebo)

Active, not recruiting
  • Acute Myeloid Leukemia
  • La Jolla, California
  • +69 more
Apr 5, 2022

Acute Myeloid Leukemia Trial in United States (Sapacitabine, Arm A, Sapacitabine, Arm B, Sapacitabine, Arm C)

Completed
  • Acute Myeloid Leukemia
  • Sapacitabine, Arm A
  • +8 more
  • Birmingham, Alabama
  • +14 more
Mar 23, 2022

Acute Myeloid Leukemia Trial in Australia, Germany, United States (AMG 673)

Terminated
  • Acute Myeloid Leukemia
  • AMG 673
  • Birmingham, Alabama
  • +6 more
Mar 17, 2022

Acute Myeloid Leukemia, Blasts 20-30 Percent of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in Baltimore,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Baltimore, Maryland
  • +2 more
Feb 25, 2022

Acute Myeloid Leukemia Trial in Worldwide (Pracinostat, Placebos, Azacitidine)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Phoenix, Arizona
  • +137 more
Mar 9, 2022

Acute Myeloid Leukemia, MDS Trial in United States (CG-806)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +9 more
Mar 4, 2022

Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • FT-2102 (olutasidenib)
  • +2 more
  • Los Angeles, California
  • +59 more
Mar 2, 2022

Acute Myeloid Leukemia Trial in Korea, Republic of, United States (HM43239)

Recruiting
  • Acute Myeloid Leukemia
  • Sacramento, California
  • +8 more
Feb 14, 2022

Acute Myeloid Leukemia, MDS Trial in Worldwide (Bemcentinib, Cytarabine, Decitabine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Iowa City, Iowa
  • +11 more
Mar 1, 2022

Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

Active, not recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Gilbert, Arizona
  • +23 more
Feb 22, 2022

Acute Myeloid Leukemia Trial in United States (Atezolizumab, Hu5F9-G4)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Sacramento, California
  • +3 more
Dec 3, 2021

Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Magrolimab
  • +6 more
  • Duarte, California
  • +25 more
Feb 4, 2022

Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts 10 Percent or More of Bone Marrow

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Cancer Fatigue Trial in Houston

Active, not recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Cognitive Behavior Therapy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 13, 2022

Acute Myeloid Leukemia Trial in United States (ASTX660, ASTX727)

Active, not recruiting
  • Acute Myeloid Leukemia
  • San Francisco, California
  • +14 more
Jan 24, 2022

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Tumor Trial in United States (APR-246, Azacitidine)

Completed
Has Results
  • Myelodysplastic Syndrome
  • +3 more
  • Tampa, Florida
  • +5 more
Jan 14, 2022